- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/80 - AcidsEsters in position 3
Patent holdings for IPC class C07D 213/80
Total number of patents in this class: 541
10-year publication summary
|
46
|
44
|
45
|
37
|
36
|
46
|
36
|
30
|
33
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Syngenta Crop Protection AG | 6577 |
18 |
| Shionogi & Co., Ltd. | 866 |
12 |
| Xwpharma Ltd. | 64 |
11 |
| Bristol-myers Squibb Company | 4789 |
9 |
| The General Hospital Corporation | 4840 |
8 |
| ViiV Healthcare Company | 165 |
8 |
| The Trustees of Columbia University in the City of New York | 3627 |
7 |
| Vertex Pharmaceuticals Incorporated | 1589 |
6 |
| Agro-kanesho Co., Ltd. | 51 |
6 |
| Almirall, S.A. | 488 |
6 |
| Laurus Labs Limited | 97 |
6 |
| Theravance Biopharma R&D IP, LLC | 416 |
6 |
| Oxular Acquisitions Limited | 21 |
6 |
| AstraZeneca AB | 2830 |
5 |
| Boehringer Ingelheim International GmbH | 4494 |
5 |
| FUJIFILM Corporation | 30327 |
5 |
| Astellas Pharma Inc. | 1035 |
5 |
| Global Blood Therapeutics, Inc. | 176 |
5 |
| Imbria Pharmaceuticals, Inc. | 67 |
5 |
| Zevra Therapeutics, Inc. | 95 |
5 |
| Other owners | 397 |